Pyng Medical Corp. Awarded Government of Canada Research Support from NRC-IRAP for the Development of Pyng’s Next Generation Intraosseous Infusion System

VANCOUVER, BRITISH COLUMBIA--(Marketwire - January 08, 2008) - Pyng Medical Corp. (TSX VENTURE: PYT) today announced the Company is receiving non-repayable research support from the National Research Council Canada Industrial Research Assistance Program (NRC-IRAP) to accelerate the development and commercialization of the Company’s second generation Intraosseous Infusion System.

MORE ON THIS TOPIC